Otorhinolaryngologic Diseases  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00436800: Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Completed
2
41
RoW
Gemcitabine, Oxaliplatin
Sanofi
Nasopharyngeal Neoplasms
10/08
10/08
NCT00439426: A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.

Completed
2
25
RoW
Oxaliplatin, capecitabine [Xeloda]
Hoffmann-La Roche
Nasopharyngeal Cancer
09/09
09/09
NCT01403259: SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Terminated
2
16
RoW
S-1 plus oxaliplatin, S-1, Oxaliplatin
Fudan University
Nasopharyngeal Carcinoma
12/14
12/15

Download Options